首页> Clinical therapeutics> Effects of lx4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects

Effects of lx4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects

导出原文传递

翻译打印收藏纠错

第一作者： Zambrowicz,B.

作者： Zambrowicz,B. ^[1] ; Ogbaa,I. ^[2] ; Frazier,K. ; Banks,P. ; Turnage,A. ; Freiman,J. ; Boehm,K.A. ; Ruff,D. ; Powell,D. ; Sands,A.

作者单位： Icon Development Solutions, San Antonio ,TX, United States ^[1] Lexicon Pharmaceuticals Inc, The Woodlands, TX, United States ^[2]

关键词 Diabetes GLP-1 PYY SGLT1 SGLT2 Urinary glucose excretion

发布时间 2013-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical therapeutics

2013年35卷8期

1162-1173页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical therapeutics

2013年35卷8期

1162-1173页

检索历史清除

Effects of lx4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects

Clinical therapeutics

相似文献

同项目论文

Clinical therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effects of lx4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects

Clinical therapeutics

相似文献

同项目论文

Clinical therapeutics

相关期刊

检索历史清除